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Managing back pain and osteoarthritis without
paracetamol
Physical treatments are the way forward
Christian Mallen NIHR research professor in general practice, Elaine Hay professor of community
rheumatology
Arthritis Research UK Primary Care Centre, Research Institute for Primary Care and Health Sciences, Keele University, Keele ST5 5BG, UK
Paracetamol (acetaminophen) is a drug we are all familiar with.
It is cheap, readily available over the counter, and is common
place in family medicine cabinets across the world. We rely on
it in the middle of the night to settle childhood fevers, and it is
usually our first choice drug for a wide range of painful
musculoskeletal disorders, including osteoarthritis and spinal
pain. Yet new evidence in a linked paper by Machado and
colleagues (doi:10.1136/bmj.h1225) casts doubt on the efficacy
and safety of paracetamol and questions its place as our first
choice analgesic.1
In their systematic review and meta-analysis examining the
efficacy and safety of paracetamol for spinal pain and
osteoarthritis, Machado and colleagues synthesised evidence
from 13 randomised controlled trials.1 They report that there is
“high quality” evidence that paracetamol is ineffective for
reducing pain intensity and disability in patients with low back
pain and “high quality” evidence that paracetamol produces a
significant but not clinically important effect on pain and
disability in patients with osteoarthritis. While adverse events
were reported at a similar level to that seen with placebo,
patients taking paracetamol were nearly four times more likely
to have abnormal results on liver function tests. These findings
encourage us to reassess the role of paracetamol as the key
analgesic in managing osteoarthritis and spinal pain.
Some of these findings are not surprising. The recently revised
guidelines from the National Institute for Health and Care
Excellence on the management of osteoarthritis caused
controversy when draft guidance advised that paracetamol
should not be routinely offered to patients as it might not be
effective and was potentially associated with important side
effects when used at high doses for a prolonged period of time.
This decision was reversed in the full guideline after concerns
from a range of stakeholders that this change in guidance might
dramatically increase the prescribing of other potentially harmful
drugs including non-steroidal anti-inflammatory drugs and
opioids.2 The Medicine and Healthcare Products Regulatory
Agency is currently reviewing the safety of over the counter
analgesics, and the findings might also influence prescribing
guidance. The new evidence provided by Machado and
colleagues re-opens the debate, leaving patients and clinicians
wondering what is left that can help to manage these common,
painful, and highly disabling conditions.
There are alternative safe and effective treatments available,
although evidence suggests that they are used inconsistently.
Over the past 10 years prescriptions for topical NSAIDs, such
as ibuprofen, have more than doubled in the UK.3 Topical
NSAIDs (such as ibuprofen) are available over the counter, are
as effective as oral NSAIDs for knee osteoarthritis, and are
associated with fewer side effects.4 They are also popular with
patients, who prefer using topical NSAIDs for mild, local, and
transient pain.5 Oral NSAIDs are effective but are best limited
to short courses in patients without contraindications—making
them unsuitable for many, especially older, patients with
multiple health conditions. The evidence supporting the use of
opioids for osteoarthritis and spinal pain is limited, and while
the UK has yet to see the dramatic increase in prescribing
observed in the United States, a reduction in the use of
paracetamol could result in increased prescribing rates and a
new range of associated problems, especially in high risk groups.
Ongoing and ever increasing concerns about pharmacological
management of musculoskeletal pain highlights the importance
of non-pharmacological options, which form the cornerstone
of self management of spinal pain and osteoarthritis. NICE
recommends that all patients with osteoarthritis should receive
written information with advice about maintaining or increasing
physical activity and optimisingweight (if appropriate); exercise,
manual therapy, acupuncture, and psychological support are
also recommended for those with back pain. While the
effectiveness of exercise for both osteoarthritis6 and spinal pain7
is established, we know that uptake of, and adherence to,
exercise is poor.8 Health professionals, particularly in primary
care, where most of these patients are managed, have an
important role to play in supporting individuals to exercise.
Physiotherapists are key professionals to offer expert advice
and support in this regard, but timely access to physiotherapy
services is becoming increasingly limited in the NHS,
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constraining the usefulness of this evidence based and safe
treatment. Trials of exercise based interventions for
musculoskeletal pain and osteoarthritis typically show the same
response pattern of a short term reduction in levels of pain and
disability with demonstrable clinical benefit tailing off over
12-24 months. Maintaining the benefit of exercise is a current
research priority, with approaches to improve adherence being
a key target.
Spinal pain and osteoarthritis are common reasons for seeking
healthcare, accounting for around 10-15% of all consultations
with a general practitioner. Management of these patients can
be challenging and is compounded by emerging evidence about
the safety and effectiveness of commonly used drugs that
conflicts with established clinical practice and published
guidelines. Changing behaviour of doctors and their patients is
notoriously difficult, but the findings ofMachado and colleagues
emphasise that the time has come to shift our attention away
from tablets as the default option for managing chronic
musculoskeletal pain. Non-pharmacological treatments work,
are safe, and have benefits that reach beyond themusculoskeletal
system. The challenge for patients, providers of healthcare, and
policy makers is how to ensure access to, uptake of, and
adherence to these self management approaches.
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